DK0868184T3 - Mikrogranula med forlænget frigivelse indeholdende diltiazem som aktivt stof - Google Patents

Mikrogranula med forlænget frigivelse indeholdende diltiazem som aktivt stof

Info

Publication number
DK0868184T3
DK0868184T3 DK96943156T DK96943156T DK0868184T3 DK 0868184 T3 DK0868184 T3 DK 0868184T3 DK 96943156 T DK96943156 T DK 96943156T DK 96943156 T DK96943156 T DK 96943156T DK 0868184 T3 DK0868184 T3 DK 0868184T3
Authority
DK
Denmark
Prior art keywords
active substance
extended release
microgranules containing
release microgranules
containing diltiazem
Prior art date
Application number
DK96943156T
Other languages
Danish (da)
English (en)
Inventor
Patrice Debregeas
Gerard Leduc
Pascal Oury
Pascal Suplie
Original Assignee
Ethypharm Lab Prod Ethiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9485856&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0868184(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ethypharm Lab Prod Ethiques filed Critical Ethypharm Lab Prod Ethiques
Application granted granted Critical
Publication of DK0868184T3 publication Critical patent/DK0868184T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
DK96943156T 1995-12-22 1996-12-23 Mikrogranula med forlænget frigivelse indeholdende diltiazem som aktivt stof DK0868184T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9515361A FR2742660B1 (fr) 1995-12-22 1995-12-22 Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif
PCT/FR1996/002040 WO1997023219A1 (fr) 1995-12-22 1996-12-23 Microgranules a liberation prolongee contenant du diltiazem comme principe actif

Publications (1)

Publication Number Publication Date
DK0868184T3 true DK0868184T3 (da) 2003-08-25

Family

ID=9485856

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96943156T DK0868184T3 (da) 1995-12-22 1996-12-23 Mikrogranula med forlænget frigivelse indeholdende diltiazem som aktivt stof

Country Status (27)

Country Link
US (3) US6228395B1 (pt)
EP (1) EP0868184B1 (pt)
JP (1) JP2000506500A (pt)
KR (1) KR100354054B1 (pt)
CN (1) CN1145488C (pt)
AR (1) AR004410A1 (pt)
AT (1) ATE238798T1 (pt)
AU (1) AU721949B2 (pt)
BG (1) BG63770B1 (pt)
BR (1) BR9612225A (pt)
CA (1) CA2242224C (pt)
DE (1) DE69627880T2 (pt)
DK (1) DK0868184T3 (pt)
EA (1) EA001721B1 (pt)
EE (1) EE04045B1 (pt)
ES (1) ES2198505T3 (pt)
FR (1) FR2742660B1 (pt)
GE (1) GEP20022629B (pt)
HK (1) HK1018400A1 (pt)
HU (1) HU224214B1 (pt)
IL (1) IL125047A (pt)
NO (1) NO324680B1 (pt)
NZ (1) NZ324739A (pt)
PL (1) PL186621B1 (pt)
PT (1) PT868184E (pt)
WO (1) WO1997023219A1 (pt)
ZA (1) ZA9610776B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2742660B1 (fr) * 1995-12-22 1998-04-03 Ethypharm Lab Prod Ethiques Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif
US6162463A (en) * 1997-05-01 2000-12-19 Dov Pharmaceutical Inc Extended release formulation of diltiazem hydrochloride
FR2790668B1 (fr) * 1999-03-12 2002-07-26 D B F Granules contenant une substance vegetale et leur procede de preparation
EP1064937A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
EP1064938A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmaceutical dosage forms for controlled release producing at least a timed pulse
US7179483B2 (en) 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
FR2831546B1 (fr) * 2001-10-31 2007-03-23 Atofina Materiau polymere thermoplastique pour supports d'enregistrement d'informations audio et/ou optiques
JP5171038B2 (ja) * 2003-10-10 2013-03-27 エティファルム イチョウ・エキスを含む放出持続性の微小顆粒およびそのような顆粒の製造方法
WO2005065715A1 (ja) * 2003-12-25 2005-07-21 Takeda Pharmaceutical Company Limited 造粒性改善方法
JP2005306778A (ja) * 2004-04-21 2005-11-04 Basf Ag 徐放性製剤及びその製造方法
WO2006013431A1 (en) * 2004-07-29 2006-02-09 Pfizer Limited Stable controlled-release pharmaceutical formulation of eletriptan
US8778395B2 (en) * 2005-08-11 2014-07-15 Andrx Labs, Llc Diltiazem controlled release formulation and method of manufacture
SI2484346T1 (sl) * 2006-06-19 2017-05-31 Alpharma Pharmaceuticals Llc Farmacevtski sestavki
ITFI20110172A1 (it) 2011-08-08 2013-02-09 Valpharma Sa Formulazione multiparticolata a rilascio modificato di diltiazem hcl.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
IT1200217B (it) * 1986-09-30 1989-01-05 Valducci Roberto Membrana per uso farmaceutico ed industriale
DK173505B1 (da) * 1987-02-20 2001-01-15 Pharmatec Internat S R L Fremgangsmåde til fremstilling af en diltiazempellet med langsom afgivelse og anvendelse af således fremstillede pelleter t
JPH07552B2 (ja) * 1987-11-06 1995-01-11 田辺製薬株式会社 持効性製剤
FR2623714B1 (fr) * 1987-11-26 1990-04-20 Ethypharm Sa Forme a liberation prolongee du diltiazem, et son medicament ainsi obtenu
FR2624732B1 (fr) * 1987-12-21 1991-02-15 Synthelabo Formulation pharmaceutique a liberation prolongee
FR2630647B1 (fr) * 1988-04-27 1991-08-16 Sanofi Sa Microbilles de diltiazem, leur procede de fabrication et compositions pharmaceutiques a liberation prolongee les contenant
US5288505A (en) 1991-06-26 1994-02-22 Galephar P.R., Inc., Ltd. Extended release form of diltiazem
US5229135A (en) * 1991-11-22 1993-07-20 Prographarm Laboratories Sustained release diltiazem formulation
US5376384A (en) 1992-12-23 1994-12-27 Kinaform Technology, Inc. Delayed, sustained-release pharmaceutical preparation
US5834024A (en) * 1995-01-05 1998-11-10 Fh Faulding & Co. Limited Controlled absorption diltiazem pharmaceutical formulation
FR2742660B1 (fr) * 1995-12-22 1998-04-03 Ethypharm Lab Prod Ethiques Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif

Also Published As

Publication number Publication date
BG63770B1 (bg) 2002-12-29
PL327567A1 (en) 1998-12-21
ATE238798T1 (de) 2003-05-15
DE69627880T2 (de) 2004-03-11
US6660296B2 (en) 2003-12-09
KR19990076717A (ko) 1999-10-15
DE69627880D1 (de) 2003-06-05
BG102555A (en) 1999-02-26
HU224214B1 (hu) 2005-06-28
EE9800197A (et) 1998-12-15
NO982738L (no) 1998-08-21
BR9612225A (pt) 1999-07-13
CA2242224C (fr) 2004-01-13
CA2242224A1 (fr) 1997-07-03
NO982738D0 (no) 1998-06-12
GEP20022629B (en) 2002-02-25
EA199800593A1 (ru) 1998-12-24
US6383516B1 (en) 2002-05-07
US6228395B1 (en) 2001-05-08
HK1018400A1 (en) 1999-12-24
JP2000506500A (ja) 2000-05-30
IL125047A0 (en) 1999-01-26
FR2742660A1 (fr) 1997-06-27
AR004410A1 (es) 1998-11-04
HUP9904129A3 (en) 2000-11-28
NZ324739A (en) 2000-01-28
AU1198397A (en) 1997-07-17
CN1145488C (zh) 2004-04-14
HUP9904129A2 (hu) 2000-04-28
WO1997023219A1 (fr) 1997-07-03
PL186621B1 (pl) 2004-02-27
FR2742660B1 (fr) 1998-04-03
EP0868184B1 (fr) 2003-05-02
PT868184E (pt) 2003-09-30
AU721949B2 (en) 2000-07-20
ZA9610776B (en) 1997-06-30
US20020182253A1 (en) 2002-12-05
NO324680B1 (no) 2007-12-03
EA001721B1 (ru) 2001-08-27
ES2198505T3 (es) 2004-02-01
EE04045B1 (et) 2003-06-16
KR100354054B1 (ko) 2003-02-14
IL125047A (en) 2003-05-29
CN1207681A (zh) 1999-02-10
EP0868184A1 (fr) 1998-10-07

Similar Documents

Publication Publication Date Title
DE69819481D1 (de) Formulierungen von clarithromycin mit verlängerter wirkstoff-freisetzung
DK0753506T3 (da) 6-Dimethylaminomethyl-1-phenyl-cyclohexanforbindelser som farmaceutisk aktive stoffer
DK0780369T3 (da) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-forbindelser som farmaceutisk virksomme stoffer
NO20012636L (no) Kontrollert frigivelsesformulering som omfatter GNRH-II
NO20012168L (no) Innretning for regulert avgivelse av aktive stoffer
EE200000155A (et) Taksoidide klassi kuuluvate derivaatide valmistamismeetod
DK1109449T3 (da) Mikrokapselformuleringer
DE69815524D1 (de) Haftende mikrokapseln enthaltend biologisch aktive substanzen
BR9607752B1 (pt) formulação farmacêutica de microcápsula de liberação controlada.
ATE264677T1 (de) Feste arzneizubereitung enthaltend benzofuranderivate
NO982324L (no) Preparat med regulert avgivelse av biologisk aktiv forbindelse
ATE255409T1 (de) Cisplatinhaltige mikrogranulate
NO984106D0 (no) Azolobenzazepin-derivater som neurologisk aktive midler
PL341141A1 (en) Application form featured by prolonged release of active substance
DK0868184T3 (da) Mikrogranula med forlænget frigivelse indeholdende diltiazem som aktivt stof
DK0975623T3 (da) Indazolamidforbindelser som sertoninerge midler
BR9407725A (pt) Sistema de liberaçao de substância ativa
FI970530A (fi) Koostumus aktiivisen aineen selektiiviseksi vapauttamiseksi
DK0805625T3 (da) Insekticidt aktiv sammensætning
NO20001847D0 (no) Ny anvendelse av forbindelser for anti-kløe-aktivitet
DE59804823D1 (de) Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung
DK1109541T3 (da) Filmformet bærer for aktivt stof
DK0747346T3 (da) N-acyl-2-arylcyclopropylmethylaminderivater som melatonerge midler
DK0625355T4 (da) Tablet med forbedret biotilgængelighed indeholdende dichlormethylendiphosphonsyre som virksomt stof
NO975567L (no) Preparat med kontrollert frigivelse av aktiv substans